PetMed Express/$PETS
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About PetMed Express
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
- Ticker
- $PETS
- Sector
- Consumer Discretionary
- Primary listing
- NASDAQ
- Employees
- 189
- Headquarters
- Delray Beach, United States
- Website
- www.1800petmeds.com
PetMed Express Metrics
BasicAdvanced
$22M
-
-$1.29
-
-
Price and volume
Market cap
$22M
52-week high
$4.10
52-week low
$1.06
Average daily volume
110K
Financial strength
Current ratio
0.598
Quick ratio
0.302
Total debt to equity
0.017
Interest coverage (TTM)
-2,864.89%
Profitability
EBITDA (TTM)
-16.628
Gross margin (TTM)
27.79%
Net profit margin (TTM)
-16.97%
Operating margin (TTM)
-16.09%
Effective tax rate (TTM)
0.23%
Revenue per employee (TTM)
$850,000
Management effectiveness
Return on assets (TTM)
-20.18%
Return on equity (TTM)
-90.76%
Valuation
Price to revenue (TTM)
0.14
Price to book
1.4
Price to tangible book (TTM)
3.6
Price to free cash flow (TTM)
-0.91
Free cash flow yield (TTM)
-109.87%
Free cash flow per share (TTM)
-1.17
Growth
Revenue change (TTM)
-19.17%
Earnings per share change (TTM)
-51.24%
3-year revenue growth (CAGR)
-16.00%
10-year revenue growth (CAGR)
-3.94%
3-year earnings per share growth (CAGR)
251.72%
10-year earnings per share growth (CAGR)
1.92%
What the Analysts think about PetMed Express
Analyst ratings (Buy, Hold, Sell) for PetMed Express stock.
Analyst projections of the future price of PetMed Express stock.
PetMed Express Financial Performance
Revenues and expenses
PetMed Express Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.